Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ASTM-AASTROM BIOSCIENCES: STEM CELL RESEARCH -- Ignore unavailable to you. Want to Upgrade?

To: Cookie Monster who wrote (247)	12/10/1998 1:29:00 PM
From: waldo	Read Replies (1) \| Respond to of 1084

2.50...4.50...6.50...it does not matter...they are saving lives now. That interests me. W

To: Cookie Monster who wrote (247)	12/10/1998 1:35:00 PM
From: TheAlaskan	Respond to of 1084

Cookie-could be, but if the media gets a hold of this breakthrough and there has been a lot of media on this subject of cord blood..it won't be at 2.50 for long. today's price will be a steal. Ole Rockefeller once said..Monopolies are good and bad.. good if we got them.. bad if we don't. It appears that ASTM has a monopoly on this very hot medical procedure and it is ready to go to market...not some backroom lab crap that is indicative of many bio techs. The company is getting scrutinized now...media will look. If its hokey it will get below your $2.50. When the world realizes its for real- multiply that number by 10. The Alaskan